Company page

Viking Therapeutics, Inc.

Viking Therapeutics, Inc. (VKTX) is a public company based in the United States with a market capitalization of approximately $3.34 billion. The company focuses on developing innovative therapies for metabolic and endocrine disorders. Viking Therapeutics is committed to advancing its pipeline of drug candidates to address significant unmet medical needs.